The 10th Symposium “Advances in Cancer Immunology & Immunotherapy” is an intensive, three days interactive meeting during which invited speakers will address the current and accumulated knowledge of basic immuno-biology and translational cancer research, as well as therapeutic developments in the field of cancer immunotherapy according to the newest clinical trials.
The scientific objectives of the 10th Symposium “Advances in Cancer Immunology and Immunotherapy” are focused on the: (a) predictive and prognostic biomarkers for immunotherapy (b) mechanisms of action of different immunotherapeutic treatments (c) the efficacy and safety data of cancer immunotherapy regimens; and (d) strategies for immunomodulation, counteracting resistance and mitigating adverse events.
This year’s Symposium will feature interactive sessions at the end of each day, where oncologists and researchers will provide their insights on the above mentioned topics in an effort to better understand tumor evolution and designing improved treatment strategies
The 10th Symposium “Advances in Cancer Immunology and Immunotherapy” welcome the participation of scientists, clinicians, students and health care professionals interested in the field of Cancer Immunology and Immunotherapy.